Search

Your search keyword '"Staelens D"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Staelens D" Remove constraint Author: "Staelens D"
26 results on '"Staelens D"'

Search Results

6. P033 Prevention of recurrent Clostridium difficile infection by neutralizing monoclonal antibodies in a hamster relapse model

7. OP19 Genetic and functional evidence for a role for CYLD in Crohn's disease: Results from a European consortium

8. Conformational variability of the synthetic peptide 129-141 of the mouse prion protein.

10. Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections

11. Reverse transcription of plasma-derived HIV-1 RNA generates multiple artifacts through tRNA(Lys-3)-priming.

12. Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led survey.

13. High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

14. Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach.

15. A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial.

16. Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART.

17. Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population.

18. Meticulous plasma isolation is essential to avoid false low-level viraemia in Roche Cobas HIV-1 viral load assays.

19. Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation.

20. Visualization of delayed release of compounds from pH-sensitive capsules in vitro and in vivo in a hamster model.

21. Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.

22. Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.

23. Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease.

24. Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients.

25. Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

26. Conformational variability of the synthetic peptide 129-141 of the mouse prion protein.

Catalog

Books, media, physical & digital resources